Why Did Histogenics Stock Drop?
The Program Was Dropped Last December After the Fda Demanded to See More Data Before They Would Accept a Bla for Review. Histogenics Shareholders Will Now...
The program was dropped last December after the FDA demanded to see more data before they would accept a BLA for review. Histogenics shareholders will now collectively hold 10% of the combined company, which will consist solely of Ocugen's lean team.
What caused Ocugen stock to fall?
Investors were concerned because the downward trend in COVID-19 cases in the United States could hurt the chances for the company's vaccine, which it is developing with India's Bharat Bioscience.
Is Ocugen Inc A Good Investment?
Ocugen has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.
Alexander Ross has covered the video game industry for a decade, writing deep dives on game design, esports tournaments, VR developments, and gaming culture.
